Compulsive habits in restless legs syndrome patients under dopaminergic treatment

Journal of the Neurological Sciences

Volumn 290, Issue 1-2, 2010, Pages 52-56

  Pourcher, Emmanuelle ^a,b,c   Rémillard, Sophie ^a   Cohen, Henri ^a,b  

^a Clinique Sainte Anne   (Canada)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

Author keywords

Compulsion; Depression; Dopaminergic treatment; Restless Legs Syndrome; Sleep problems; Stress

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLONUS; COMPULSION; DEPRESSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SIDE EFFECT; SLEEP DISORDER; STRESS; STRUCTURED QUESTIONNAIRE; TRICHOTILLOMANIA; WEIGHT GAIN;

ADULT; AGED; BENZOTHIAZOLES; COMPULSIVE BEHAVIOR; DEPRESSIVE DISORDER; DOPAMINE AGONISTS; EATING DISORDERS; FEMALE; GAMBLING; HEALTH STATUS; HEALTH SURVEYS; HUMANS; LIMBIC SYSTEM; MALE; MIDDLE AGED; MOOD DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; REWARD; SLEEP DISORDERS; STRESS, PSYCHOLOGICAL; TRICHOTILLOMANIA;

EID: 74849090939     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.11.010     Document Type: Article

References (33)

1. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 10 (1995) 634-642
2. Garcia-Borreguero D., Odin P., and Schwarz C. Restless legs syndrome: an overview of the current understanding and management. Acta Neurol Scand 109 (2004) 303-317
3. Hening W., Walters A.S., Allen R.P., Montplaisir J., Myers A., and Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5 (2004) 237-246
4. Wetter T.C., Eisensehr I., and Trenkwalder C. Functional neuroimaging studies in restless legs syndrome. Sleep Med 5 (2004) 401-406
5. Trenkwalder C., Paulus W., and Walters A.S. The restless legs syndrome. Lancet Neurol 4 (2005) 465-475
6. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord 19 (2004) 367-370
7. Friedman J.H. Punding on levodopa. Biol Psychiatry 36 (1994) 350-351
8. Fernandez H.H., and Friedman J.H. Punding on L-dopa. Mov Disord 14 (1999) 836-838
9. Molina J.A., Sainz-Artiga M.J., Fraile A., Jiménez-Jiménez F.J., Villanueva C., Orti-Pareja M., et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?. Mov Disord 15 (2000) 869-872
10. Driver-Dunckley E., Samanta J., and Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 61 (2003) 422-423
11. Nirenberg M.J., and Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 21 (2006) 524-529
12. Weintraub D., Siderowf A.D., Potenza M.N., Goveas J., Morales K.H., Duda J.E., et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63 (2006) 969-973
13. Mamikonyan E., Siderowf A.D., Duda J.E., Potenza M.N., Horn S., Stern M.B., et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 23 (2008) 75-80
14. Voon V., Hassan K., Zurowski M., Duff-Canning S., de Souza M., Fox S., et al. Prospective prevalence of pathologic gambling and medication association in Parkinson's disease. Neurology 66 (2006) 1750-1752
15. Voon V., Thomsen T., Miyasaki M., de Souza M., Shafro A., Fox S.H., et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64 (2007) 212-216
16. Klos K.J., Bowers J.H., Josephs K.A., Matsumoto J.Y., and Ahlskog J.E. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 11 (2005) 381-386
17. Pontone G., Williams J.R., Bassett S.S., and Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 67 (2006) 1258-1261
18. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67 (2006) 1254-1257
19. Quickfall J., and Suchowersky O. Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord 13 (2007) 535-536
20. Tippmann-Peikert M., Park J.G., Boeve B.F., Shepard J.W., and Silber M.H. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68 (2007) 301-303
21. Walters A.S., LeBrocq C., Dhar A., Hening W., Rosen R., Allen R.P., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
22. Beck A.T., Steer R.A., and Brown G.K. Manual for the Beck Depression Inventory - II (1996), Psychological Corporation, San Antonio, TX
23. Hays R.D., and Stewart A.L. Sleep measures. In: Alsje E. (Ed). Measuring functioning and well-being: The Medical Outcomes Study approach (1992), Duke University Press, Durham, NC 235-259
24. Hays R.D., Martin S.A., Sesti A.M., and Spritzer K.L. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 6 (2005) 41-44
25. Evans A.H., Katzenschlager R., Paviour D., O'Sullivan J.D., Appel S., Lawrence A.D., et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19 (2004) 397-405
26. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington
27. SPSS I., SPSS graduate pack for Mac OS X, Version 17, 2008, Chicago, Illinois.
28. Ritz F., Lesperance P., and Panisset M. Addictive behaviours in RLS patients on dopaminergic agonists. Mov Disord 21-15 (2006) S 662-S 663
29. Okuji Y., Matsuura M., Kawasaki N., Kometani S., Shimoyama T., Sato M., et al. Prevalence of insomnia in various psychiatric diagnostic categories. Psychiatry Clin Neurosci 56 (2002) 239-240
30. Uhde T.W. Anxiety disorders. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine (2000), Saunders WB Company 1123-1139
31. Benca R.M. Mood disorders. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and practice of sleep medicine (2000), Saunders WB Company 1140-1157
32. Claghorn J.L., Mathew R.J., Weinman M.L., and Hruska N. Daytime sleepiness in depression. J Clin Psychiatry 42 (1981) 342-343
33. Walter P., and Trenkwalder C. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 5 (2006) 878-886